These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 32827167

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. False-negative solid-phase platelet crossmatch results due to prozone phenomenon.
    Horton RK, Zuccarelli MD, Wakefield LL, DiGuardo MA, Gandhi MJ, Juskewitch JE.
    Transfusion; 2020 Dec; 60(12):3055-3059. PubMed ID: 33047855
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP, Nambiar A.
    Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J, Lim YM, Park KD, Han BY, Kim YH, Han KS, Park MH.
    Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. When O Bites Back: Unrecognized Acute Hemolytic Reaction from Out-of-Group HLA-Compatible Platelet Transfusion.
    Pasion JO, Song LH, McCusker MG, Shimer L, Bryant A, McGann HL, Fontaine MJ.
    Ann Clin Lab Sci; 2021 Mar; 51(2):267-270. PubMed ID: 33941569
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation.
    Marktel S, Napolitano S, Zino E, Cappelli B, Chiesa R, Poli F, Crocchiolo R, Ronchi P, Rossini S, Ciceri F, Roncarolo MG, Fleischhauer K.
    Pediatr Transplant; 2010 May; 14(3):393-401. PubMed ID: 20070557
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation.
    Peng B, Zhuang Q, Yu M, Li J, Liu Y, Zhu L, Ming Y.
    Med Sci Monit; 2019 Feb 03; 25():952-961. PubMed ID: 30712055
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
    Fagundes IS, Franz JM, Jobim MS, Arend A, Merzoni J, Cardone JM, Gil B, Sekine L, Jobim LF.
    Hum Immunol; 2020 May 03; 81(5):197-201. PubMed ID: 32067841
    [Abstract] [Full Text] [Related]

  • 18. Incompatible crossmatch: First sign of a hemolytic transfusion reaction due to out-of-group platelet transfusion.
    Basu D, Basu S, Roy J, Reddy M, Chandy M, Bhaumik J.
    Asian J Transfus Sci; 2019 May 03; 13(1):57-59. PubMed ID: 31360013
    [Abstract] [Full Text] [Related]

  • 19. Prospective platelet crossmatching for selection of compatible random donors.
    Freedman J, Hooi C, Garvey MB.
    Br J Haematol; 1984 Jan 03; 56(1):9-18. PubMed ID: 6367808
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.